Kohno Takayuki, Wada Atsushi, Igarashi Yasuyuki
Department of Biomembrane and Biofunctional Chemistry, Graduate School of Pharmaceutical Sciences, Hokkaido University, Japan.
FASEB J. 2002 Jul;16(9):983-92. doi: 10.1096/fj.01-0809com.
Endothelial differentiation gene-1 product (Edg-1) is a G-protein-coupled receptor (GPCR) for the platelet derived bioactive lipid mediator sphingosine 1-phosphate (Sph-1-P). Recent studies have shown that in response to Sph-1-P, Edg-1 mediates various signaling pathways through downstream signaling molecules, such as MAP kinase and calcium, via heterotrimeric G-proteins. We found for the first time that Edg-1 is glycosylated in its amino-terminal extracellular portion, and further identified the specific glycosylation site as asparagine 30 by creating a nonglycosylated mutant of Edg-1 (N30D-Edg-1) and transfecting it into cell lines. The nonglycosylated mutant receptors, resembling their wild-type controls, were predominantly expressed in the plasma membrane. Although there was no difference in ligand binding ability and ligand-induced MAP kinase activation in the wild-type and mutant receptors, nonglycosylated Edg-1 was much less responsive for ligand-induced internalization. Unlike the wild-type receptor, which was associated with the caveolae, nonglycosylated N30D-Edg-1 was dispersed broadly in the membrane fractions separated by sucrose density gradient centrifugation, suggesting that internalization and microdomain localization of N-glycosylated Edg-1 might be related. Although the precise molecular mechanism of the internalization of the N-glycosylated Edg-1 localized in the microdomain remains to be examined, the present study suggested that the presence of N-linked glycan in the receptor may play a regulatory role in the receptor dynamics in ligand-stimulated mammalian cells.
内皮分化基因-1产物(Edg-1)是血小板衍生的生物活性脂质介质鞘氨醇1-磷酸(Sph-1-P)的G蛋白偶联受体(GPCR)。最近的研究表明,响应Sph-1-P时,Edg-1通过异源三聚体G蛋白,经由下游信号分子(如丝裂原活化蛋白激酶和钙)介导各种信号通路。我们首次发现Edg-1在其氨基末端细胞外部分发生糖基化,并通过创建Edg-1的非糖基化突变体(N30D-Edg-1)并将其转染到细胞系中,进一步确定了特定的糖基化位点为天冬酰胺30。非糖基化突变体受体与野生型对照相似,主要表达于质膜。虽然野生型和突变体受体在配体结合能力和配体诱导的丝裂原活化蛋白激酶激活方面没有差异,但非糖基化的Edg-1对配体诱导的内化反应要弱得多。与与小窝相关的野生型受体不同,非糖基化的N30D-Edg-1广泛分散在通过蔗糖密度梯度离心分离的膜组分中,这表明N-糖基化的Edg-1的内化和微区定位可能有关。虽然定位于微区的N-糖基化Edg-1内化的确切分子机制仍有待研究,但本研究表明受体中N-连接聚糖的存在可能在配体刺激的哺乳动物细胞中的受体动力学中发挥调节作用。